INVO Fertility, Inc. (IVF) Form 10-K — Jun 2, 2026
INVO Fertility, Inc. reported an accumulated net loss of $91.4 million since inception and disclosed substantial doubt about its ability to continue as a going concern, stating that current cash is insufficient to fund operations and service debt for the next 12 months. The company executed three reverse stock splits in 2025 and 2026 (ratios of 1:12, 1:8, and 1:5) to maintain its Nasdaq listing, and received deficiency letters from Nasdaq for failing to file its 10-K and 10-Q reports on time.
Key figures
- Revenue
- 0
- Net Income
- 0
- Total Debt
- 0
- Cash Position
- 0
- Shares Outstanding
- 1786035
- Market Value Non Affiliate
- 2185985
- Jag notes principal
- 660000
- Naya note principal
- 4803175
- Reverse split ratios
- ["1:12","1:8","1:5"]
- Pritts settlement amount
- 6000000
- Dec 2025 private placement
- 4000000
- Jan 2025 offering proceeds
- 9500000
- Apr 2025 warrant exercise proceeds
- 750000
- Jan 2026 warrant exercise proceeds
- 7500000
- Family beginnings acquisition price
- 760000
Price after filing
Close on the filing date to close N calendar days later (from $1.52). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.